Actual medications may vary depending on the prescribing provider, pharmacy, and applicable regulations
Other reported effects Beyond GI symptoms, clinical trials noted several other effects worth monitoring: Increased heart rate: A small, dose-dependent increase in resting heart rate was observed, consistent with what occurs with other GLP-1 agonists
Zepbound: Generally begins at 2.5 mg given once weekly, with the potential to increase by 2.5 mg every 4 weeks until reaching an effective maintenance dose, which can range from 5 mg to 15 mg
Profhilo Structura: results build over 23 sessions and can last 612 months
Marker Health emphasizes: "Injection site rotation isnt optional nice-to-have advice
Theres uncertainty around the effectiveness of microdosing compounded versions of GLP-1s and a lack of research on the safety of this method